View in EDS PDF Full Text

Psychosocial Status and Quality of Life in Patients With Ménière's Disease and Vestibular Migraine.

Saved in:
Bibliographic Details
Title: Psychosocial Status and Quality of Life in Patients With Ménière's Disease and Vestibular Migraine.
Authors: Karababa, Ercan1 ody.ercan.ek@gmail.com, Akın Öçal, Fatma Ceyda2, Akbaş, Rumeysa Nur1, Sunar, Abdullah3, Aydın, Emine2
Source: American Journal of Audiology. Dec2025, Vol. 34 Issue 4, p919-926. 8p.
Subject Terms: *Disability determination, *Emotions, *Quality of life, *Comparative studies, Diagnosis of mental depression, Anxiety diagnosis, Sleep disorder diagnosis, Pearson correlation (Statistics), Mental health, Vestibular migraine, Dizziness, Questionnaires, Ménière's disease, Functional status, Psychological well-being, Chi-squared test, Data analysis software, Disease complications
Abstract: Purpose: The objective of this study was to evaluate anxiety, depression, dizziness disability, sleep, and quality of life in individuals diagnosed with Ménière's disease (MD) and vestibular migraine (VM). Additionally, the study sought to examine the impact of anxiety and depression levels, as well as dizziness disability, on sleep and quality of life. Method: The present study included a total of 51 individuals, with 25 subjects in the MD group and 26 subjects in the VM group. The Beck Anxiety Inventory (BAI), the Beck Depression Inventory (BDI), the Dizziness Handicap Inventory (DHI), the 36-Item Short Form Health Survey (SF-36) for quality of life, and the Pittsburgh Sleep Quality Index (PSQI) were administered face-to-face to all subjects. Results: A statistically significant difference was not observed between the two groups in terms of BDI, BAI, DHI total, and subcategories (Emotional, Physical, and Functional; p > .05). Among the subdimensions of SF-36, only Vitality and Mental Health scores were found to be statistically significantly higher in the MD group compared to the VM group (p = .039 and p = .030, respectively). Conversely, the PSQI score exhibited a statistically significant difference, with higher values observed in the VM group compared to the MD group (p = .023). Conclusions: VM and MD significantly impact psychological and physiological outcomes, including anxiety, depression, dizziness, quality of life, and sleep. Psychiatric comorbidities and reduced quality of life profoundly affect daily life. Therefore, a multidisciplinary approach, including psychiatric support, is essential for effective management. [ABSTRACT FROM AUTHOR]
Copyright of American Journal of Audiology is the property of American Speech-Language-Hearing Association and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Education Research Complete
Description
Abstract:Purpose: The objective of this study was to evaluate anxiety, depression, dizziness disability, sleep, and quality of life in individuals diagnosed with Ménière's disease (MD) and vestibular migraine (VM). Additionally, the study sought to examine the impact of anxiety and depression levels, as well as dizziness disability, on sleep and quality of life. Method: The present study included a total of 51 individuals, with 25 subjects in the MD group and 26 subjects in the VM group. The Beck Anxiety Inventory (BAI), the Beck Depression Inventory (BDI), the Dizziness Handicap Inventory (DHI), the 36-Item Short Form Health Survey (SF-36) for quality of life, and the Pittsburgh Sleep Quality Index (PSQI) were administered face-to-face to all subjects. Results: A statistically significant difference was not observed between the two groups in terms of BDI, BAI, DHI total, and subcategories (Emotional, Physical, and Functional; p > .05). Among the subdimensions of SF-36, only Vitality and Mental Health scores were found to be statistically significantly higher in the MD group compared to the VM group (p = .039 and p = .030, respectively). Conversely, the PSQI score exhibited a statistically significant difference, with higher values observed in the VM group compared to the MD group (p = .023). Conclusions: VM and MD significantly impact psychological and physiological outcomes, including anxiety, depression, dizziness, quality of life, and sleep. Psychiatric comorbidities and reduced quality of life profoundly affect daily life. Therefore, a multidisciplinary approach, including psychiatric support, is essential for effective management. [ABSTRACT FROM AUTHOR]
ISSN:10590889
DOI:10.1044/2025_AJA-25-00065